These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27834199)

  • 1. The Continuing Quest to Identify Ambulatory Patients With Advanced Heart Failure Who Benefit From Left Ventricular Assist Device Therapy.
    Wever-Pinzon O; Drakos SG
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834199
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management).
    Stehlik J; Estep JD; Selzman CH; Rogers JG; Spertus JA; Shah KB; Chuang J; Farrar DJ; Starling RC;
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
    Starling RC; Estep JD; Horstmanshof DA; Milano CA; Stehlik J; Shah KB; Bruckner BA; Lee S; Long JW; Selzman CH; Kasirajan V; Haas DC; Boyle AJ; Chuang J; Farrar DJ; Rogers JG;
    JACC Heart Fail; 2017 Jul; 5(7):518-527. PubMed ID: 28396040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced heart failure treated with continuous-flow left ventricular assist device.
    Slaughter MS; Rogers JG; Milano CA; Russell SD; Conte JV; Feldman D; Sun B; Tatooles AJ; Delgado RM; Long JW; Wozniak TC; Ghumman W; Farrar DJ; Frazier OH;
    N Engl J Med; 2009 Dec; 361(23):2241-51. PubMed ID: 19920051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure.
    Baras Shreibati J; Goldhaber-Fiebert JD; Banerjee D; Owens DK; Hlatky MA
    JACC Heart Fail; 2017 Feb; 5(2):110-119. PubMed ID: 28017351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putting Life in the Years: Incorporating Quality of Life Into Left Ventricular Assist Devices Outcomes.
    Stewart GC
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507114
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term use of a left ventricular assist device for end-stage heart failure.
    Rose EA; Gelijns AC; Moskowitz AJ; Heitjan DF; Stevenson LW; Dembitsky W; Long JW; Ascheim DD; Tierney AR; Levitan RG; Watson JT; Meier P; Ronan NS; Shapiro PA; Lazar RM; Miller LW; Gupta L; Frazier OH; Desvigne-Nickens P; Oz MC; Poirier VL;
    N Engl J Med; 2001 Nov; 345(20):1435-43. PubMed ID: 11794191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roads, Maps, and Destinations: the Journey of Left Ventricular Assist Device Implantation in Ambulatory Patients with Advanced Heart Failure.
    Trachtenberg BH; Estep JD
    Curr Cardiol Rep; 2016 Dec; 18(12):132. PubMed ID: 27837385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HeartWare left ventricular assist device for the treatment of advanced heart failure.
    Hanke JS; Rojas SV; Avsar M; Bara C; Ismail I; Haverich A; Schmitto JD
    Future Cardiol; 2016 Jan; 12(1):17-26. PubMed ID: 26597386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: design and rationale of the ROADMAP clinical trial.
    Rogers JG; Boyle AJ; O'Connell JB; Horstmanshof DA; Haas DC; Slaughter MS; Park SJ; Farrar DJ; Starling RC
    Am Heart J; 2015 Feb; 169(2):205-210.e20. PubMed ID: 25641529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices.
    Luo N; Rogers JG; Dodson GC; Patel CB; Galanos AN; Milano CA; O'Connor CM; Mentz RJ
    Am J Cardiol; 2016 Sep; 118(5):733-8. PubMed ID: 27474339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.
    Grady KL; Meyer PM; Dressler D; Mattea A; Chillcott S; Loo A; White-Williams C; Todd B; Ormaza S; Kaan A; Costanzo MR; Piccione W
    Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HeartMate II left ventricular assist device: a new device for advanced heart failure.
    Delgado R; Bergheim M
    Expert Rev Med Devices; 2005 Sep; 2(5):529-32. PubMed ID: 16293063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience.
    Adamson RM; Stahovich M; Chillcott S; Baradarian S; Chammas J; Jaski B; Hoagland P; Dembitsky W
    J Am Coll Cardiol; 2011 Jun; 57(25):2487-95. PubMed ID: 21679851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic relief: left ventricular assist devices versus resynchronization therapy.
    Delgado RM; Radovancevic B
    Heart Fail Clin; 2007 Jul; 3(3):259-65. PubMed ID: 17723934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On Target: Optimum International Normalized Ratio for Left Ventricular Assist Device Patients.
    Connors JM
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.